论文部分内容阅读
目的分析江西省肿瘤登记地区2011—2013年肺癌发病和死亡情况,为制定肺癌预防控制措施提供依据。方法根据江西省6个肿瘤登记地区2011—2013年肺癌的发病和死亡资料,分析肺癌粗发病率、粗死亡率、标化率、累积率、截缩率、潜在减寿年(PYLL)、减寿率(PYLLR)和平均减寿年数(AYLL)。结果 2011—2013年江西省肿瘤登记地区肺癌粗发病率为43.08/10万,中国人口标化发病率为26.48/10万,世界人口标化发病率为35.88/10万,累积发病率(0~74岁)为4.47%;粗死亡率为27.98/10万,中国人口标化死亡率为16.54/10万,世界人口标化死亡率为22.67/10万,累积死亡率(0~74岁)为2.77%。肺癌发病率和死亡率男性高于女性,且随着年龄的增长而升高。肺癌的PYLL和AYLL分别为14 199人年和8.26年,其中男性分别为10 471人年和8.20年,女性分别为3 728人年和8.42年。结论江西省肿瘤登记地区肺癌的发病和死亡低于全国平均水平,男性和中老年人是肺癌防治的重点人群,应重视女性因肺癌早亡现象。
Objective To analyze the incidence and mortality of lung cancer in Jiangxi Cancer Registry from 2011 to 2013 and provide the evidence for the development of prevention and control measures for lung cancer. Methods According to the incidence and mortality data of lung cancer in 6 cancer registration areas from 2011 to 2013 in Jiangxi Province, the crude incidence rate, crude mortality rate, standardization rate, accumulation rate, truncation rate, potential life expectancy (PYLL) Life expectancy (PYLLR) and the average number of years of life lost (AYLL). Results The crude incidence rate of lung cancer was 43.08 / 100 000 in Jiangxi Cancer Registry Area from 2011 to 2013. The incidence of lung cancer in China was 26.48 / 100 000, the incidence rate of world population standardized was 35.88 / 100 000, the cumulative incidence rate was 0 ~ 74 years old) was 4.47%. The crude death rate was 27.98 / 100000. The standardized death rate in China was 16.54 / 100000. The world’s population standardized death rate was 22.67 / 100000. The cumulative death rate (0-74 years) was 2.77%. The incidence and mortality of lung cancer are higher in males than in females and increase with age. PYLL and AYLL for lung cancer were 14,199 and 8.26 years, respectively, of which 10,471 were men and 8.22 were women, respectively, and 3,728 and 8.42 were women respectively. Conclusions The incidence and mortality of lung cancer in the area of cancer registration in Jiangxi Province are lower than the national average. Men and middle-aged and elderly people are the key population for lung cancer prevention and treatment. Premature death due to lung cancer should be emphasized in women.